---
title: '#IDWeek2023 Posts/Tweets Analysis'
author: Ken Koon Wong
date: '2023-10-22'
slug: idweek2023
categories: 
- idweek2023
- idweek23
- tweets
- posts
- twitter
- x
- learning
- gganimate
- twitter api v2
tags: 
- idweek2023
- idweek23
- tweets
- posts
- twitter
- x
- learning
- gganimate
- twitter api v2
excerpt: "Immersed in gratitude and inspiration at #IDWeek2023 üåê! A massive thank you to everyone who contributed - your posts were a beacon of warmth and wisdom. üåü Celebrating the triumphs of award recipients üèÜ, your remarkable achievements propel us all forward! Enlightened by the groundbreaking insights from new trials, we are reminded to remain humble and passionate in our continuous quest for knowledge. Together, we will continue unveiling the realms of Infectious Disease, advancing with unity and purpose!" 
---
<script src="{{< blogdown/postref >}}index_files/kePrint/kePrint.js"></script>
<link href="{{< blogdown/postref >}}index_files/lightable/lightable.css" rel="stylesheet" />
<script src="{{< blogdown/postref >}}index_files/kePrint/kePrint.js"></script>
<link href="{{< blogdown/postref >}}index_files/lightable/lightable.css" rel="stylesheet" />
<script src="{{< blogdown/postref >}}index_files/kePrint/kePrint.js"></script>
<link href="{{< blogdown/postref >}}index_files/lightable/lightable.css" rel="stylesheet" />
<script src="{{< blogdown/postref >}}index_files/kePrint/kePrint.js"></script>
<link href="{{< blogdown/postref >}}index_files/lightable/lightable.css" rel="stylesheet" />
<script src="{{< blogdown/postref >}}index_files/kePrint/kePrint.js"></script>
<link href="{{< blogdown/postref >}}index_files/lightable/lightable.css" rel="stylesheet" />
<script src="{{< blogdown/postref >}}index_files/kePrint/kePrint.js"></script>
<link href="{{< blogdown/postref >}}index_files/lightable/lightable.css" rel="stylesheet" />

> Immersed in gratitude and inspiration at #IDWeek2023 üåê! A massive thank you to everyone who contributed - your posts were a beacon of warmth and wisdom. üåü Celebrating the triumphs of award recipients üèÜ, your remarkable achievements propel us all forward! Enlightened by the groundbreaking insights from new trials, we are reminded to remain humble and passionate in our continuous quest for knowledge. Together, we will continue unveiling the realms of Infectious Disease, advancing with unity and purpose! 


![](full.png)

Wordcloud of all the `#IDweek2023` tweets/posts.    

If you want to look at the specific tweets, I have created a shiny app that helps me to glance through essential topics. Here is the [link](https://kenkoonwong.shinyapps.io/shiny_idweek23/)


# Thought Process:
- [Post counts by days](#count) 
- [Top 50 X Users Post Counts](#top50)
- [Posts frequency separated by dates](#animate)
- [Top 5 Liked Posts Seperated by Dates ](#like)
- [Top 20 Bookmarked Posts](#bookmark)
- [Top 20 Bookmarked Posts Usernames](#bookmark-user)
- [IDtwitter vs IDxPost ?](#idtwitter)
- [Limitations](#limit)
- [Acknowledgement](#ack)
- [Lessons learnt](#lesson)




<br>

## Post counts by days {#count}
![](posts_days.png)
Very interesting. When compared to IDweek 2022, there is a difference in post peaks. This year it appears more bimodal (Thursday and Saturday) whereas last year it peaked on Friday. This year it also appeared that posts were more than last year, which is great! We had a total of 2627 posts this year, and last year was ~2188.    

<br>

## Top 50 X Users Post Counts {#top50}
![](top50.png)
Thanks to all who have contributed. SIDPharm, SAIRABT, LordAlirezaF, CalderwoodMD, AHRQNews, TxIDdoc, HishamZenith, ABsteward, DocWoc71, IDWeekmtg leading the top 10 posts combined. Can you find your handle here?

<br>

## Posts frequency separated by dates {#animate}

![](anim.gif)
Who is leading the posts is dynamic! Everyday during IDweek is different! That's ok. Thank you all again for contributing to #idweek2023. For those who are not there in person, this really makes us feel like we're there! 

<br>

## Top 5 Liked Posts Seperated by Dates {#like}
#### 10-11-23
<table>
 <thead>
  <tr>
   <th style="text-align:left;"> date </th>
   <th style="text-align:left;"> username </th>
   <th style="text-align:left;"> text </th>
  </tr>
 </thead>
<tbody>
  <tr>
   <td style="text-align:left;"> 2023-10-11 </td>
   <td style="text-align:left;"> mmPharmD </td>
   <td style="text-align:left;"> Are you ready for it?!?  #IDWeek2023 #SIDP2023 https://t.co/mwArh66fqU </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-11 </td>
   <td style="text-align:left;"> GermHunterMD </td>
   <td style="text-align:left;"> Didyaknow? EPIC-SR has resulted

@JGPharmD with ü´ñ 

Outpatient paxlovid didn‚Äôt ‚¨áÔ∏è Covid-related hospitalization &amp;amp; death in unvacc‚Äôd patients with standard risk or vaccinated high-risk patients (unlike in prevax era)

Are these still right endpoints?

#IDWeek2023 #MedIQ23IDWeek https://t.co/ZhqWcJz31W </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-11 </td>
   <td style="text-align:left;"> eeeejjjaaaa </td>
   <td style="text-align:left;"> #IDWeek2023 first day! https://t.co/EJLhxf1BQR </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-11 </td>
   <td style="text-align:left;"> SundermannAJ </td>
   <td style="text-align:left;"> #IDTwitter meet up success! 

Loving meeting &amp;amp; seeing these folks in-person!

@AlainnaJJ @mmPharmD @dr_pbailey @DrRossanaRosa @dralicehan @HIVDocSK 

#IDWeek2023 https://t.co/Ev5RR3fyiT </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-11 </td>
   <td style="text-align:left;"> NEJM </td>
   <td style="text-align:left;"> Original Article: Decolonization in Nursing Homes to Prevent Infection and Hospitalization https://t.co/MqqEVtX0NV 

#IDWeek2023 https://t.co/OvvjUNH1tt </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-11 </td>
   <td style="text-align:left;"> GermHunterMD </td>
   <td style="text-align:left;"> Women üèÉ‚Äç‚ôÄÔ∏è the table at #IDWeek2023

Sue Swindells - @IDSAInfo Fleming Lifetime Achievement Award
Judith Feinberg - @HIVMA Transformative Leader 
Victoria Fraser - @SHEA_Epi Sr Scholar
Pat Flynn - @PIDSociety Distinguished Researcher
@julie_justo - @SIDPharm Outstanding Clinician https://t.co/oHu6aOmPyS </td>
  </tr>
</tbody>
</table>

Interesting to see that outpatient paxlovid didn‚Äôt ‚¨áÔ∏è Covid-related hospitalization, death in unvacc‚Äôd patients with standard risk or vaccinated high-risk patient, but when looked at mITT for both seronegative (NNT=10) and positive patients (NNT=67), it did. 

Also interesting to see that, in nursing homes, universal decolonization with chlorhexidine and nasal iodophor led to a significantly lower risk of transfer to a hospital due to infection than routine care. 

![](101123.png)

<br>

#### 10-12-23
<table>
 <thead>
  <tr>
   <th style="text-align:left;"> date </th>
   <th style="text-align:left;"> username </th>
   <th style="text-align:left;"> text </th>
  </tr>
 </thead>
<tbody>
  <tr>
   <td style="text-align:left;"> 2023-10-12 </td>
   <td style="text-align:left;"> ABsteward </td>
   <td style="text-align:left;"> üî• JUST PUBLISHED üî• 
@IDSAInfo @SCCM Guideline for the evaluation of new-onset fever in adult ICU patients without severe immunocompromise
12 recommendations[all weak based]
9 best practice statements 
#IDXposts #IDWeek2023
H/t @YukiKotani5
Thanks @Inox94 https://t.co/0kY8H6jrC0 https://t.co/4nbYLcBshB </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-12 </td>
   <td style="text-align:left;"> GermHunterMD </td>
   <td style="text-align:left;"> I have a VERY IMPORTANT announcement

#IDWeek2023 has PUPPIES!!!!! https://t.co/FUD3AiuGnP </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-12 </td>
   <td style="text-align:left;"> taliaswartz </td>
   <td style="text-align:left;"> Incredibly humbled to receive the Oswald Avery Award at #IDWeek2023 and grateful for mentorship and inspiration in the field of #ID. #WeAreID  @CarlosdelRio7 https://t.co/G8O0ha9jxa </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-12 </td>
   <td style="text-align:left;"> GermHunterMD </td>
   <td style="text-align:left;"> Clinical trials that may change your practice

#IDWeek2023 üßµ </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-12 </td>
   <td style="text-align:left;"> emilylheil </td>
   <td style="text-align:left;"> Conferences need more puppies. Well done #IDWeek2023 https://t.co/rXDa1nx8qY </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-12 </td>
   <td style="text-align:left;"> mmPharmD </td>
   <td style="text-align:left;"> #IDWeek2023 achievement unlocked!  @PaulSaxMD has been found and has been gifted an @SIDPharm bracelet!  @IDWeekmtg https://t.co/iEF9AeNhy7 </td>
  </tr>
</tbody>
</table>

Can't wait to tuck into [Society of Critical Care Medicine and the Infectious Diseases Society of America Guidelines for Evaluating New Fever in Adult Patients in the ICU](https://journals.lww.com/ccmjournal/fulltext/2023/11000/society_of_critical_care_medicine_and_the.13.aspx). ABsteward always has the latest ID article. 


Wait a minute... IDWeek2023 has puppies üê∂ !? Cool!

Thanks to GermHunter for summarizing and turn our lenses to üî• Clinical Trials that may change your practice. 
1. [PALACE](https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2806976) - Open label RCT w [PEN-FAST](https://www.mdcalc.com/calc/10422/penicillin-allergy-decision-rule-pen-fast) score less than 3, direct oral penicillin challenge was noninferior compared with standard-of-care skin testing followed by oral challenge. 
2. [Ceftobiprole vs daptomycin for Staph aureus bacteremia](https://www.nejm.org/doi/full/10.1056/NEJMoa2300220#:~:text=In%20this%20double%2Dblind%20trial,either%20MRSA%20or%20MSSA%20infection) - non-inferior.
3. [ATTACK trial](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00184-6/fulltext) - sulbactam‚Äìdurlobactam was non-inferior to colistin
4. [Doxycycline PEP](https://www.nejm.org/doi/10.1056/NEJMoa2211934?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed) - The combined incidence of gonorrhea, chlamydia, and syphilis was lower by two thirds with doxycycline postexposure prophylaxis than with standard care
5. [more...](https://twitter.com/GermHunterMD/status/1712530126972268604) 

![](101223.png)

<br>
<br>

#### 10-13-23
<table>
 <thead>
  <tr>
   <th style="text-align:left;"> date </th>
   <th style="text-align:left;"> username </th>
   <th style="text-align:left;"> text </th>
  </tr>
 </thead>
<tbody>
  <tr>
   <td style="text-align:left;"> 2023-10-13 </td>
   <td style="text-align:left;"> MeetJess </td>
   <td style="text-align:left;"> Intranasal COVID Vaccine Generates Strong Immune Response 

We need this .. yesterday  https://t.co/PuC6mraOLn </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-13 </td>
   <td style="text-align:left;"> Sandyboots2020 </td>
   <td style="text-align:left;"> Intranasal COVID Vaccine Generates Strong Immune Response.

They can‚Äôt come soon enough.
 https://t.co/O2TCCFLpF8 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-13 </td>
   <td style="text-align:left;"> destmauricemd </td>
   <td style="text-align:left;"> @PeterHotez congratulations on winning the Anthony Fauci Courage in Leadership Award. Thank you for all you do! #idweek https://t.co/zmVhLg4Mhe </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-13 </td>
   <td style="text-align:left;"> EdselSalvana </td>
   <td style="text-align:left;"> Got a photo with one of my idols! Unflappable science &amp;amp; vaccine advocate Dr. 
@PeterHotez ! Whenever I feel attacked on social media for pushing back against anti-vaxxers, I take inspiration from his example! Congratulations on your award and please keep on inspiring us! #IDWeek https://t.co/JAxPMIsov0 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-13 </td>
   <td style="text-align:left;"> khalideljaaly </td>
   <td style="text-align:left;"> Very honored to be inducted as a Fellow of Infectious Diseases Society of America @IDSAInfo 
I would like to thank everyone who supported me 
 #IDWeek2023 https://t.co/hzxdJuHre7 </td>
  </tr>
</tbody>
</table>

Wow. Very interesting. Intranasal covid vaccine with strong response! üí™

![](101323.png)
<br>
<br>

#### 10-14-23
<table>
 <thead>
  <tr>
   <th style="text-align:left;"> date </th>
   <th style="text-align:left;"> username </th>
   <th style="text-align:left;"> text </th>
  </tr>
 </thead>
<tbody>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> JAMA_current </td>
   <td style="text-align:left;"> Among hospitalized adults, the risk of acute kidney injury did not differ between cefepime and piperacillin-tazobactam, but neurological dysfunction was more common with cefepime. #IDWeek2023 https://t.co/5PbD8XuTLG https://t.co/RGPUyAVahe </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> mangarone23 </td>
   <td style="text-align:left;"> Best quote of #IDWeek2023 or any IDWeek @NM_IDSteward https://t.co/raEDgSoS2I </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> LordAlirezaF </td>
   <td style="text-align:left;"> üìÉUpcoming Guidelines Spoilers #IDWeek2023
First-ever IDSA guidelines for complicated Urinary Tract Infection (cUTI) #UTI https://t.co/QpLPOamb7y </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> JAMA_current </td>
   <td style="text-align:left;"> Editorial: Acute Kidney Injury With Empirical Antibiotics for Sepsis #IDWeek2023 https://t.co/hoFM2vuDFV https://t.co/QCnFPnaT82 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> ABsteward </td>
   <td style="text-align:left;"> üî•The ACORN RCTüî•
N: 2511
Cefepime vs Piperacillin tazobactam in Adults Hospitalized With Acute Infection w/in 12h presentation to ER/ICU
AKI did not differ between FEP &amp;amp; TZP , but neurological dysfunction more common with FEP
H/t @DrToddLee #IDWeek2023
https://t.co/ZjqiZi3X54 https://t.co/yE4MgBjLjU </td>
  </tr>
</tbody>
</table>

<p align="center">
  <img src="acorn.jpg" alt="image" width="10%" height="auto">
  </p>

This day is all about the [ACORN](https://jamanetwork.com/journals/jama/article-abstract/2810592)! Among hospitalized adults in this randomized clinical trial, treatment with piperacillin-tazobactam did not increase the incidence of acute kidney injury or death. Treatment with cefepime resulted in more neurological dysfunction.






Also, nice to know that IDSA has new cUTI guideline! Thanks LordAlirezaF!



![](cuti.png)
Good to know the new definition of uncomplicated UTI (everything else both in men and women if does not have pyelo, CAUTI or febrile/bacteremic). Wait, CAUTI is complicated?

![](101423.png)
<br>
<br>

#### 10-15-23
<table>
 <thead>
  <tr>
   <th style="text-align:left;"> date </th>
   <th style="text-align:left;"> username </th>
   <th style="text-align:left;"> text </th>
  </tr>
 </thead>
<tbody>
  <tr>
   <td style="text-align:left;"> 2023-10-15 </td>
   <td style="text-align:left;"> JAMA_current </td>
   <td style="text-align:left;"> Published with #IDWeek2023

ACORN RCT: Among hospitalized adults, treatment with piperacillin-tazobactam did not increase incidence of AKI or death. 

Treatment with cefepime resulted in more neurological dysfunction.

Tap link for full trial results.

https://t.co/5PbD8XuTLG https://t.co/j3WFhELJ4u </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-15 </td>
   <td style="text-align:left;"> GermHunterMD </td>
   <td style="text-align:left;"> Reflecting on a wonderful #IDWeek2023, thinking about all the #IDTwitter connections and community we stand to lose - and all the benefits that the next generation will miss - with the demise of Twitter https://t.co/BuxlUXqBrV </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-15 </td>
   <td style="text-align:left;"> noufkmag </td>
   <td style="text-align:left;"> Using social media platforms is a powerful tool of education by attracting more young learners into the field of infectious diseases. Thank you Dr. @PaulSaxMD for your continuous contribution to social media by sharing scientific updates in literature! @IDWeekmtg #IDWeek2023 https://t.co/LWh5Z4z7Pq </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-15 </td>
   <td style="text-align:left;"> zsulaiman13 </td>
   <td style="text-align:left;"> One of my favorite talks of the meeting by #IDTwitter legend @Cortes_Penfield 

We can consider highly bioavailable oral antibiotics to treat patients with bone and joint infections (oral step down after 2 weeks of IV therapy) - doxycycline + FQs ü¶¥üôåüèΩ

#IDWeek2023 @UNMC_ID https://t.co/bou8vgcobQ </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-15 </td>
   <td style="text-align:left;"> noufkmag </td>
   <td style="text-align:left;"> I was honored to present our research work under the lead of Dr. Farmakiotis @DFarmakiotis on the utility of CMV-specific T-cell mediated immunity panel (TCIP) to predict protection against CMV among kidney transplant recipients #IDWeek2023 #IDWeekmtg #WeAreID #TxID https://t.co/tWAebxTXwk </td>
  </tr>
</tbody>
</table>

Last but not least, more studies on oral antibiotics for osteomyelitis! 

![](101523.png)

<br>
<br>

## Top 20 Bookmarked Posts {#bookmark}
<table>
 <thead>
  <tr>
   <th style="text-align:left;"> date </th>
   <th style="text-align:left;"> username </th>
   <th style="text-align:left;"> text </th>
  </tr>
 </thead>
<tbody>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> LordAlirezaF </td>
   <td style="text-align:left;"> üìÉUpcoming Guidelines Spoilers #IDWeek2023
First-ever IDSA guidelines for complicated Urinary Tract Infection (cUTI) #UTI https://t.co/QpLPOamb7y </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-12 </td>
   <td style="text-align:left;"> ABsteward </td>
   <td style="text-align:left;"> üî• JUST PUBLISHED üî• 
@IDSAInfo @SCCM Guideline for the evaluation of new-onset fever in adult ICU patients without severe immunocompromise
12 recommendations[all weak based]
9 best practice statements 
#IDXposts #IDWeek2023
H/t @YukiKotani5
Thanks @Inox94 https://t.co/0kY8H6jrC0 https://t.co/4nbYLcBshB </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> JAMA_current </td>
   <td style="text-align:left;"> Among hospitalized adults, the risk of acute kidney injury did not differ between cefepime and piperacillin-tazobactam, but neurological dysfunction was more common with cefepime. #IDWeek2023 https://t.co/5PbD8XuTLG https://t.co/RGPUyAVahe </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-12 </td>
   <td style="text-align:left;"> GermHunterMD </td>
   <td style="text-align:left;"> Clinical trials that may change your practice

#IDWeek2023 üßµ </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> mangarone23 </td>
   <td style="text-align:left;"> Best quote of #IDWeek2023 or any IDWeek @NM_IDSteward https://t.co/raEDgSoS2I </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-13 </td>
   <td style="text-align:left;"> MeetJess </td>
   <td style="text-align:left;"> Intranasal COVID Vaccine Generates Strong Immune Response 

We need this .. yesterday  https://t.co/PuC6mraOLn </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> ABsteward </td>
   <td style="text-align:left;"> üî•The ACORN RCTüî•
N: 2511
Cefepime vs Piperacillin tazobactam in Adults Hospitalized With Acute Infection w/in 12h presentation to ER/ICU
AKI did not differ between FEP &amp;amp; TZP , but neurological dysfunction more common with FEP
H/t @DrToddLee #IDWeek2023
https://t.co/ZjqiZi3X54 https://t.co/yE4MgBjLjU </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-12 </td>
   <td style="text-align:left;"> cynth_ID </td>
   <td style="text-align:left;"> Have Epic? It only takes 10 min with SlicerDicer to see what outpatient durations of therapy are being prescribed at your institution. @n_mercuro #IDWeek2023 https://t.co/BNDLSBS10C </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> JAMA_current </td>
   <td style="text-align:left;"> Editorial: Acute Kidney Injury With Empirical Antibiotics for Sepsis #IDWeek2023 https://t.co/hoFM2vuDFV https://t.co/QCnFPnaT82 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-13 </td>
   <td style="text-align:left;"> Sandyboots2020 </td>
   <td style="text-align:left;"> Intranasal COVID Vaccine Generates Strong Immune Response.

They can‚Äôt come soon enough.
 https://t.co/O2TCCFLpF8 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> KatieCinnamon </td>
   <td style="text-align:left;"> üî•üî• IDSA cUTI Clinical Guideline Updates:
-UTI definitions updated
-Duration of therapy for cUTI = 7 days for most patients

#IDWeek2023 #IDTwitter #TwitteRx #SIDP2023 https://t.co/3MIRlYMvws </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-13 </td>
   <td style="text-align:left;"> TxIDdoc </td>
   <td style="text-align:left;"> #IDWeek2023¬†

UTI in Renal Tx R¬†
37.8% bacteremia in UTI with KTRx¬†
No Sx, No UTI¬†

Can treating ASB decrease pyelonephritis? ‚ÄúNot 1st 2months‚Äù¬†

- Not really ‚û°Ô∏èmore resistant bugs!¬†

Optimal duration in IC pts? 7 vs 14 d?¬†

Rec UTI: Voiding cystourethrogram w neg imaging https://t.co/ufmq9AwaXb </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> SAIRABT </td>
   <td style="text-align:left;"> #idweek2023 @IDWeekmtg Oral Therapy for Staphylococcus aureus Bacteremia: Routine, in Whom, When and for How Long? by Dr. George Sakoulas #idtwitter #SAB #MRSA 1/ https://t.co/69fKJeYaN2 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-15 </td>
   <td style="text-align:left;"> zsulaiman13 </td>
   <td style="text-align:left;"> One of my favorite talks of the meeting by #IDTwitter legend @Cortes_Penfield 

We can consider highly bioavailable oral antibiotics to treat patients with bone and joint infections (oral step down after 2 weeks of IV therapy) - doxycycline + FQs ü¶¥üôåüèΩ

#IDWeek2023 @UNMC_ID https://t.co/bou8vgcobQ </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> GermHunterMD </td>
   <td style="text-align:left;"> Good morning, #IDTwitter 

Live tweeting top papers in mycology at #IDWeek2023

Starting with Monica Slavin on top 10 clinical mycology papers https://t.co/3VoLrGkGl3 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-13 </td>
   <td style="text-align:left;"> TxIDdoc </td>
   <td style="text-align:left;"> #IDWeek2023¬†
Cryptococcosis¬†
Rec 1st line by host and how Rx came along¬†
Different approaches due to Rx, fluc 2000 mg?!¬†
Manage raised ICP!, prolong induction if csf remains Cx pos¬†
Don‚Äôt escalate for persistent Ag wo pos Cx https://t.co/1DL5L9Pia8 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-14 </td>
   <td style="text-align:left;"> edenhelmi </td>
   <td style="text-align:left;"> &quot;Oral Therapy for Staph. Bacteremia- Routine, In Whom, When, and How Long&quot;
George Sakoulas

The induction phase (IV-lead tx) will influence the success/failure of the consolidation phase (PO step-down) in SAB 

#IDWeek2023 https://t.co/Fhncdk66vu </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-15 </td>
   <td style="text-align:left;"> SAIRABT </td>
   <td style="text-align:left;"> #idweek2023 @IDWeekmtg Clinical Trials in #Fungal Diseases That May Change Your Practice: presented by
Dr George Thompson III 1/ #idtwitter https://t.co/UuioiLymga </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-13 </td>
   <td style="text-align:left;"> ABsteward </td>
   <td style="text-align:left;"> üÜïÔ∏è‚ö°Ô∏èüî•Systematic review and meta-analysis @Crit_Care
PCT-guided antibiotic therapy may be associated with reduced AB use, lower 28-day mortality but higher infection recurrence, with similar ICU and hospital length of stay #IDXposts #idweek2023
https://t.co/HWJp6o5Bvc https://t.co/egOq75yiOx </td>
  </tr>
  <tr>
   <td style="text-align:left;"> 2023-10-12 </td>
   <td style="text-align:left;"> ABsteward </td>
   <td style="text-align:left;"> Linezolid/Rifampin interaction is substantial &amp;amp; stronger than previously reported
üÜïÔ∏è‚ö°Ô∏èPK analysis from POET RCT
Rifampicin ‚¨áÔ∏èplasma concentration of linezolid in pts with IE
Would this PK interaction alter clinical efficacy? #IEwiki #IDweek2023 #idxposts https://t.co/jMcasePvW9 </td>
  </tr>
</tbody>
</table>

Top 20 bookmarked posts were quite consistent with like counts. I won't repeat the findings here but highlight the ones not mentioned. 

1. [Institutes with EPIC SlicerDicer may play a role in antibiotic prescription surveillance and more.](https://t.co/BNDLSBS10C) 
2. [Treating ASB in kidney translant apparently does not decrease pyelo in the first 2 months.](https://twitter.com/TxIDdoc/status/1712816321975525880)
3. More oral antibiotic talks, now this one is on [staph aureus bacteremia](https://twitter.com/SAIRABT/status/1713175195924513099)
4. [Top papers in mycology.](https://twitter.com/GermHunterMD/status/1713163589740081286) 
5. [PCT-guided antibiotics therapy may be associated with reduce AB use](https://twitter.com/ABsteward/status/1712887391411667374)
6. [Linezolid/Rifampin interaction is substantial](https://academic.oup.com/jac/advance-article-abstract/doi/10.1093/jac/dkad316/7308566?login=false)

<br>

## Top 20 Bookmarked Posts Usernames {#bookmark-user}
<img src="{{< blogdown/postref >}}index_files/figure-html/unnamed-chunk-8-1.png" width="672" />

Wow, looks like ABsteward is taking the lead on the most bookmarked posts, followered by JAMA_current, GermHunterMD, LordAlirezaF and more. Thank you all for keeping all of us informed! I definitely feel like I was there with all these great posts!

<br>

## IDtwitter vs IDxPost ? {#idtwitter}
<img src="{{< blogdown/postref >}}index_files/figure-html/unnamed-chunk-9-1.png" width="672" />

It looks like most people are still using #IDtwitter on X! At least for those tagged with #idweek2023. It's a good representation of ID audience on X. 

<p align="center">
  <img src="idtwitter.jpeg" alt="image" width="30%" height="auto">
  </p>

<br>

## Limitations {#limit}
- Data only queried with (#Idweek2023 AND idweek)
- Data on 10/11 may not be as accurate re: like counts etc due to delayed extraction, 
- All data extracted on 10/18 8a hence all counts are uptodate until then
- Some 10/11 author_id we were unable to find username
- Not all top likes / bookmark counts mean posts are helpful, same for the converse  
- Helpful posts may not have #idweek2023 and not be extracted (e.g. @dralicehan's posts)
- Posts do not mean information accurate but definitely help in stimulating reading the source
- Lots of interesting talks in ID week that may not have been shared in X
- I found wordcloud not too helpful this year, hence I used likes and bookmark to further guide posts that were favored by X crowds.

<br>

## Acknowledgement {#ack}


Thank you @CalderwoodMD @MSG_ERC @SIDPharm @DrToddLee @blandman19 @TAInfDis @JAMANetwork @MayoClinicINFD @rk3 @CCO_Education @idpharmd @IDWeekmtg @HishamZenith @DocWoc71 @LizHighleyman @Mav_Rust @IUIDfellowship @CUP_med_health @HMS_MI @LenaHeung @DrPHO_ID @edenhelmi @LordAlirezaF @TxIDdoc @IDSAInfo @marisurueda @michael_david1 @InfectDisNews @Darcy_ID_doc @greenbergepi @WebsEdge_Med @MelintaTx @ABsteward @IDPharmacist @IDstewardship @ICT_magazine @mmPharmD @SundermannAJ @Letstalkmicro1 @swinndong @SAIRABT @IDWeekOutBREAK @aliciaelr @HFHInfDisFellow @NeilKuMD @PIDSociety @JAMA_current @cynth_ID @Contagion_Live @Mic_Inf_Maranon @GermHunterMD @AHRQNews @dralicehan for keeping #idweek2023 virtual crowd on X lively! This is by no means sorted in order, it's sorted top 50 users who posted the most and then randomly sorted for acknowledgement. ‚ù§Ô∏è

My apologies if your handle is not here. Everyone who have contributed, we are immensely grateful for your contribution! üôè

<br>

## Lessons Learnt {#lesson}
- finally learnt how to navigate twitter api v2 without `rtweet`, it's not too hard! 
- learnt pagination on twitter api
- learnt `gganimate` 
- learnt a lot of about ID news! Thanks to the contributors!

If you're interested at #IDweek2022 Tweet Analysis, please click [here](https://www.kenkoonwong.com/blog/idweek2022/), no animation back then though. ü§£

<br>

If you like this article:
  - please feel free to send me a [comment or visit my other blogs](https://www.kenkoonwong.com/blog/)
- please feel free to follow me on [twitter](https://twitter.com/kenkoonwong/), [GitHub](https://github.com/kenkoonwong/) or [Mastodon](https://med-mastodon.com/@kenkoonwong)
- if you would like collaborate please feel free to [contact me](https://www.kenkoonwong.com/contact/)
